Skip to main content
Hindustan Bio Sciences Ltd. logo

Hindustan Bio Sciences Ltd. — Investor Relations & Filings

Ticker · 532041 ISIN · INE597C01021 BSE.NS Manufacturing
Open in API
Filings indexed 2 across all filing types
Latest filing 2026-05-21 Regulatory Filings
Country IN India
Listing BSE.NS 532041

About Hindustan Bio Sciences Ltd.

https://www.hindustanbiosciences.in/

Hindustan Bio Sciences Ltd. specializes in the development, production, and distribution of pharmaceutical formulations and biotechnology-derived products. The company focuses on several therapeutic areas, including nephrology, oncology, and general medicine. Its portfolio includes recombinant human erythropoietin (EPO), vaccines, and a variety of specialized medicinal treatments. The organization emphasizes the delivery of high-quality healthcare solutions through advanced manufacturing processes and research-driven methodologies. By addressing complex medical needs, the company serves healthcare providers and patients with a range of therapeutic interventions designed to improve clinical outcomes.

Recent filings

Filing Released Lang Actions
Annual Secretarial Compliance Report for the year ended 31 March 2026
Regulatory Filings Classification · 95% confidence The document is an Annual Secretarial Compliance Report submitted under Regulation 24A(2) of SEBI (LODR) Regulations, 2015. It is a compliance submission by the Company Secretary, not a full financial report (10-K, IR, AR) nor an earnings release, dividend notice, etc. It is neither a notice of an upcoming report nor a mere announcement of publication, but the actual regulatory compliance report itself. This type of officer certification and regulatory compliance filing falls under the ‘Regulatory Filings’ (RNS) category as a general regulatory announcement and compliance document.
2026-05-21 English
Hindustan Bio Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve Hindustan Bio Sciences ....
Regulatory Filings Classification · 66% confidence The document is a formal intimation under SEBI LODR Regulation 29 announcing the date and agenda of a Board of Directors meeting to consider audited financial results and audit report. It does not itself contain financial data, nor is it the actual report, nor an AGM/EGM notice, nor a dividend or management change announcement. It is a generic regulatory disclosure notice to the stock exchange and therefore best fits the fallback category “Regulatory Filings” (RNS).
2026-05-19 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.